A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell (Q33361776)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell |
scientific article |
Statements
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell (English)
Massimo Loda
Robert I Haddad
Lisa J Weinstein
Tad J Wieczorek
Nandita Bhattacharya
Harry Raftopoulos
Martin W Oster
Xinxin Zhang
Vaughan M Latham
Rosemary Costello
Jarrod Faucher
Carolyn DeRosa
Murray Yule
Linda P Miller
Marshall R Posner